Golden Biotech will showcase at BIO Asia 2023 and hold a seminar
Exhibitor: GOLDEN BIOTECHNOLOGY CORP.
Date: 2023-07-30
Booth No.: L318
Golden Biotech will showcase at BIO Asia Taiwan 2023 and hold a seminar
Join us to discover the groundbreaking results of our latest clinical trial.
Golden Biotechnology Corp (GBC, “GoldenBiotech”, TPEx: 4132), an advanced biopharma dedicated to developing innovative new drugs. Its investigational new drug is a New Chemical Entity (NCE) with multiple functions. It has completed Phase 2 trials in Non-Small Cell Lung Cancer (NSCLC), Acute Myeloid Leukemia (AML), pancreatic cancer, and COVID-19. The interim report of the Phase 2 trial for first-line treatment of metastatic pancreatic cancer had released.
Its investigationsl new drug has received Orphan Drug Designation (ODD) from the FDA for AML, pancreatic cancer, and Hepatocellular Carcinoma (HCC), as well as from the EU for pancreatic cancer.
Golden Biotech welcomes inquiries and discussions from potential partners.
1. BIO Asia Taiwan 2023 Exhibition
Time: 7/27 ~ 7/30, 10:00~18:00.
Pharma Area : L 318.
Hall 1, 4F, Nangang Exhibition Center, Taipei, Taiwan
2. Bio Asia Taiwan 2023, Golden Biotech Seminar
Topic: Changing the Treatment Paradigm for Pancreatic Cancer
Speakers:
Boon-Kean Choy / GM
Penny Chen, MD / Medical Director
Time: 2023/7/28 (Fri.), 11:30-12:20
Room 502, Hall 1, 5th F, Nangang Exhibition Center, Taipei, Taiwan
*Note: This information serves as an introduction and research information for BIO Asia Taiwan 2023, and does not constitute advertising for food or drugs.
More Exhibitor's Press Release
- Comparison of Maglev Centrifugal Pump and Quaternary Diaphragm Pump Effects on mRNA encapsulated LNP LEVITRONIX GMBH TAIWAN BRANCH / 2023-08-02
- Evolution of Upstream Bioprocessing for Viral Vector Production LEVITRONIX GMBH TAIWAN BRANCH / 2023-08-02
- TFF Shear Stress Investigations on Levitronix® Single-Use Centrifugal Pumps LEVITRONIX GMBH TAIWAN BRANCH / 2023-08-02
- Life Science FVG Cluster CLUSTER SCIENZE DELLA VITA DEL FRIULI VENEZIA GIULIA - POLO TECNOLOGICO ALTO ADRIATICO ANDREA GALVANI / 2023-07-29
- Taiwan FDA granted the API Market License of Ponatinib HCI "GBC" GENOVIOR BIOTECH CORP. / 2023-07-29
- Co-development partner wanted for the following injection projects GENOVIOR BIOTECH CORP. / 2023-07-29
- EU Partners submit MAA to several EU member states, and expect EU GMP site audit conducted in 2024. GENOVIOR BIOTECH CORP. / 2023-07-29
- IKG Medtech Co., Ltd. "IKG Long-distance Reablement Service" and "IKG Leg Power King" integrate the IKG MEDTECH CO., LTD. / 2023-07-29
- NYCU's Anivance AI Revolutionizes Animal Testing Models with Biomimetic Organs-on-Chips Technology! NYCU-GUAN-YU CHEN / 2023-07-28
- Exonox’ platform technology could deliver patient stratification and clinical trial enrichment EXONOX BIOSCIENCES, INC. / 2023-07-28
- As a HUB of European medical industry, Italy participates in Bio Asia 2023 ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2023-07-27
- Exonox has completed the prototype kit for non-invasive monitoring of renal function decline in DN EXONOX BIOSCIENCES, INC. / 2023-07-27
- HANCHORBIO ANNOUNCES TFDA IND APPROVAL FOR HCB101 TO TREAT SOLID AND HEMATOLOGICAL MALIGNANCIES HANCHORBIO INC. / 2023-07-26
- Labtech pioneers compliant airflow monitoring and control solutions for laboratories LABTECH EQUIPMENT CORP. / 2023-07-26
- Labtech offers comprehensive solutions for laboratory ventilation furniture and equipment LABTECH EQUIPMENT CORP. / 2023-07-26
- Labtech x TRIPOWER Showcase Lab Design and Planning Competence LABTECH EQUIPMENT CORP. / 2023-07-26
- Open Lab Day : 16th/17th/18th August 2023 MALVERN PANALYTICAL / 2023-07-26
- NanoSight Pro Launch: Characterizing Bionanomaterials has never been so quick, easy and accurate! MALVERN PANALYTICAL / 2023-07-26
- Malvern Panalytical Taiwan offers full-fledged application and sales support, even for particle size MALVERN PANALYTICAL / 2023-07-26
- Dangerous high rate myopia, Eyemikan Myopia Services to protect the occurrence of critical vision. EYEMIKAN BIOTECH INC. / 2023-07-25
